Inventors:
Vassil Iliya Ognyanov - Franklin Park NJ, US
Laurence A. Borden - Hackensack NJ, US
Stanley Charles Bell - Narberth PA, US
Jing Zhang - East Brunswick NJ, US
Assignee:
Allelix Neuroscience Inc. - Salt Lake City UT
International Classification:
A61P 25/00
A61K 31/38
A61K 31/67
A61K 31/36
A61K 31/34
C07D 333/00
C07D 311/00
C07D 317/00
C07D 307/00
C07F 9/00
US Classification:
514438, 514 95, 514 96, 514 99, 514100, 514101, 514437, 514443, 514444, 514445, 514447, 514448, 514454, 514455, 514465, 514466, 514469, 514470, 514471, 514472, 549 5, 549 6, 549 26, 549 27, 549 51, 549 54, 549 55, 549 57, 549 58, 549 59, 549 60, 549 61, 549 63, 549 64, 549 65, 549 68, 549 69, 549 71, 549 72, 549 74, 549 75, 549 76, 549 77, 549218, 549220, 549221, 549222, 549385, 549390, 549391, 549392, 549393, 549394, 549395, 549434, 549435, 549436, 549437, 549438, 549439, 549440, 549441, 549442, 549443, 549444, 549466, 549467, 549472, 549473, 549474, 549476, 549478, 549479, 549480, 549481, 549483, 549484, 549485, 549486, 549487, 549488, 549491, 549496
Abstract:
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof.